Singapore markets closed

CANbridge Pharmaceuticals Inc. (1228.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
0.340-0.015 (-4.23%)
At close: 03:59PM HKT
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in CNY. All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
87,295
78,972
31,161
12,032
Cost of revenue
33,891
30,078
12,385
5,154
Gross profit
53,404
48,894
18,776
6,878
Operating expenses
Research development
295,889
311,174
427,658
109,642
Selling general and administrative
183,959
195,689
246,265
128,724
Total operating expenses
471,394
498,409
673,518
237,971
Operating income or loss
-417,990
-449,515
-654,742
-231,093
Interest expense
8,840
6,863
3,079
3,794
Income before tax
-452,624
-483,475
-1,077,006
-846,043
Income tax expense
0
0
0
0
Income from continuing operations
-452,624
-483,475
-1,077,006
-846,043
Net income
-452,624
-483,475
-1,077,006
-846,043
Net income available to common shareholders
-452,624
-483,475
-1,077,006
-846,043
Basic EPS
-1.06
-1.14
-11.43
-1.99
Diluted EPS
-1.06
-1.14
-11.43
-1.99
Basic average shares
424,268
424,211
94,241
424,192
Diluted average shares
424,268
424,211
94,241
424,192